These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18256759)

  • 1. Cell sensitivity to reaferon in patients with renal cell cancer after reaferon therapy.
    Shkapova EA; Kurtasova LM; Savchenko AA
    Bull Exp Biol Med; 2007 Jul; 144(1):80-2. PubMed ID: 18256759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The production of active forms of oxygen by neutrophils in volunteers receiving leukinferon and reaferon].
    Sirina EG; Tugutova IV; Zmyzgova AV; Iushchuk ND; Mesniankin AP
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):93-7. PubMed ID: 2385996
    [No Abstract]   [Full Text] [Related]  

  • 3. [The results of clinical trials and the prospects of using the Soviet preparation of human recombinant interferon alpha-2 (reaferon) in medical practice].
    Kalinin IuT; Vorob'ev AA; Bumialis VV; Denisov LA; Parfenov VV; Klenova AV; Ianulaĭtis AA; Ershov FI; Marchenko VI; Malinovskaia VV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):61-7. PubMed ID: 2256404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roferon-A in solid tumor therapy.
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):1-50. PubMed ID: 2919287
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of reaferon on the functional activity of peripheral blood lymphocytes and neutrophils of volunteers].
    Gabrilovich DI; Serebrovskaia LV; Murzabaeva RT; Semashko MI; Zmyzgova AV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):61-5. PubMed ID: 3389006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reaferon in the treatment of hemorrhagic fever with the renal syndrome].
    Ivanov KS; Roshchupkin VI; Koshil' OI; Morozov VG; Utkin VN
    Antibiot Khimioter; 1994 Jan; 39(1):42-6. PubMed ID: 8060195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.
    Fosså SD; Gunderson R; Moe B
    Cancer; 1990 Jun; 65(11):2451-4. PubMed ID: 2337859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative analysis of the effect of alpha 2-interferon (reaferon) therapy on the morphofunctional state of the bone marrow in patients with chronic myeloleukemia].
    Abdulkadyrov KM; Rukavitsyn OA; Moiseev SI; Rugal' VI
    Gematol Transfuziol; 1993 Mar; 38(3):11-3. PubMed ID: 8020725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
    Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
    Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon treatment of renal cell carcinoma. Current status and future prospects.
    Krown SE
    Cancer; 1987 Feb; 59(3 Suppl):647-51. PubMed ID: 10822464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
    Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
    Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dynamic production of interferons, interleukins and arachidonic acid metabolites by the blood cells of children with glomerulonephritis associated with HB virus infection while treated with reaferon].
    Markarian AS; Malinovskaia VV; Dlin VV; Ignatov MS; Asratian AA; Pronin AV
    Vopr Virusol; 1993; 38(4):152-6. PubMed ID: 7694426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
    Grups JW; Komprecht B
    J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma.
    Ueno Y; Sohma T
    Ann Intern Med; 1992 Aug; 117(3):266-7. PubMed ID: 1616229
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant interferon-alpha 2 antibodies in renal cell carcinoma. Delta-P Study Group.
    Prümmer O; Porzsolt F
    J Interferon Res; 1994 Aug; 14(4):193-5. PubMed ID: 7822873
    [No Abstract]   [Full Text] [Related]  

  • 17. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
    May M; Helke C; Bock M; Hoschke B
    Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of exogenous and endogenous interferonization in preventing influenza].
    Ershov FI; Grigorian SS; Semenenko TA; Malinovskaia VV; Tarasenko OA; Agafonov VI; Prozorovskiĭ SV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):42-5. PubMed ID: 1724860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia].
    Abdulkadyrov KM; Moiseev SI; Shcherbakova EG; Balashova VA; Glazanova TV; Rukavitsyn OA; Martynkevich IS; Gritsaev SV; Blinov MN
    Ter Arkh; 1995; 67(6):59-63. PubMed ID: 7667786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of recombinant interferon alpha-C.
    Merimsky O; Rubinstein M; Fischer D; Danon A; Chaitchik S
    Cancer Chemother Pharmacol; 1991; 27(5):406-8. PubMed ID: 1999003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.